143 related articles for article (PubMed ID: 21436869)
1. RNAi-mediated COPS3 gene silencing inhibits metastasis of osteogenic sarcoma cells.
Yan T; Tang G; Ren T; Shen D; Sun K; Liang W; Guo W
Cancer Gene Ther; 2011 Jun; 18(6):450-6. PubMed ID: 21436869
[TBL] [Abstract][Full Text] [Related]
2. Novel oncogene COPS3 interacts with Beclin1 and Raf-1 to regulate metastasis of osteosarcoma through autophagy.
Zhang F; Yan T; Guo W; Sun K; Wang S; Bao X; Liu K; Zheng B; Zhang H; Ren T
J Exp Clin Cancer Res; 2018 Jul; 37(1):135. PubMed ID: 29970115
[TBL] [Abstract][Full Text] [Related]
3. COPS3 amplification and clinical outcome in osteosarcoma.
Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
[TBL] [Abstract][Full Text] [Related]
4. COPS3 inhibition promotes cell proliferation blockage and anoikis via regulating PFKFB3 in osteosarcoma cancer cells.
Zhang F; Li Q; Zhang Y; Li N; Rao M; Li S; Ai Z; Yan S; Tian Z
Eur J Pharmacol; 2023 Jul; 951():175799. PubMed ID: 37201626
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of COPS3 inhibits the progress of prostate cancer through reducing phosphorylated p38 MAPK expression and impairs the epithelial-mesenchymal transition process.
Zhu Z; Hong Y; Zhang F; An L; Yang Q; Huang X; Xu Q
Prostate; 2019 Dec; 79(16):1823-1831. PubMed ID: 31509289
[TBL] [Abstract][Full Text] [Related]
6. The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma.
Niu J; Yan T; Guo W; Wang W; Ren T; Huang Y; Zhao Z; Yu Y; Chen C; Huang Q; Lou J; Guo L
Autophagy; 2023 Jun; 19(6):1693-1710. PubMed ID: 36451342
[TBL] [Abstract][Full Text] [Related]
7. Silencing of the COPS3 gene by siRNA reduces proliferation of lung cancer cells most likely via induction of cell cycle arrest and apoptosis.
Wang XM; Cui JW; Li W; Cai L; Song W; Wang GJ
Asian Pac J Cancer Prev; 2012; 13(3):1043-8. PubMed ID: 22631635
[TBL] [Abstract][Full Text] [Related]
8. High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma.
Fuchs B; Mahlum E; Halder C; Maran A; Yaszemski M; Bode B; Bolander M; Sarkar G
Gene; 2007 Sep; 399(2):137-43. PubMed ID: 17560052
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of COPS3 promotes clear cell renal cell carcinoma progression via regulation of Phospho-AKT(Thr308), Cyclin D1 and Caspase-3.
Hong Y; Huang X; An L; Ye H; Ma K; Zhang F; Xu Q
Exp Cell Res; 2018 Apr; 365(2):163-170. PubMed ID: 29477618
[TBL] [Abstract][Full Text] [Related]
10. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
11. Vasodilator-stimulated phosphoprotein regulates osteosarcoma cell migration.
Wu G; Wei L; Yu A; Zhang M; Qi B; Su K; Hu X; Wang J
Oncol Rep; 2011 Dec; 26(6):1609-15. PubMed ID: 21874265
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.
Su Y; Wagner ER; Luo Q; Huang J; Chen L; He BC; Zuo GW; Shi Q; Zhang BQ; Zhu G; Bi Y; Luo J; Luo X; Kim SH; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Yang K; Wietholt C; Li M; Qin J; Haydon RC; He TC; Luu HH
Oncogene; 2011 Sep; 30(37):3907-17. PubMed ID: 21460855
[TBL] [Abstract][Full Text] [Related]
13. High WT1 expression is associated with very poor survival of patients with osteogenic sarcoma metastasis.
Srivastava A; Fuchs B; Zhang K; Ruan M; Halder C; Mahlum E; Weber K; Bolander ME; Sarkar G
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4237-43. PubMed ID: 16857797
[TBL] [Abstract][Full Text] [Related]
14. COPS3 Promotes Proliferation, Invasion, and EMT of Colorectal Cancer Cells by MEK/ERK Pathway.
Xie Y; Wei Z; Cheng C
Dis Markers; 2022; 2022():7594489. PubMed ID: 35903293
[TBL] [Abstract][Full Text] [Related]
15. COPS3 AS lncRNA enhances myogenic differentiation and maintains fast-type myotube phenotype.
He ZZ; Zhao T; Qimuge N; Tian T; Yan W; Yi X; Jin J; Cai R; Yu T; Yang G; Pang W
Cell Signal; 2022 Jul; 95():110341. PubMed ID: 35491006
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic Properties of Candidate Oncogenes in Chromosome Region 17p11.2p12 in Human Osteosarcoma.
Both J; Wu T; Ten Asbroek AL; Baas F; Hulsebos TJ
Cytogenet Genome Res; 2016; 150(1):52-59. PubMed ID: 27846620
[TBL] [Abstract][Full Text] [Related]
17. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.
Mu Y; Zhang L; Chen X; Chen S; Shi Y; Li J
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072914
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of matrix metalloproteinase-3 in human osteosarcoma and its association with tumor metastasis.
Huang JF; Du WX; Chen JJ
J BUON; 2016; 21(5):1279-1286. PubMed ID: 27837634
[TBL] [Abstract][Full Text] [Related]
19. CPNE1 silencing inhibits the proliferation, invasion and migration of human osteosarcoma cells.
Jiang Z; Jiang J; Zhao B; Yang H; Wang Y; Guo S; Deng Y; Lu D; Ma T; Wang H; Wang J
Oncol Rep; 2018 Feb; 39(2):643-650. PubMed ID: 29207139
[TBL] [Abstract][Full Text] [Related]
20. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
Zucchini C; Manara MC; Cristalli C; Carrabotta M; Greco S; Pinca RS; Ferrari C; Landuzzi L; Pasello M; Lollini PL; Gambarotti M; Donati DM; Scotlandi K
J Exp Clin Cancer Res; 2019 Dec; 38(1):503. PubMed ID: 31878963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]